BioLife Solutions (BLFS) Appoints Timothy L. Moore to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
BioLife Solutions Appoints Cell Therapy Executive Timothy L. Moore to its Board of Directors
August 25, 2022 8:03 AM EDTIndustry veteran brings extensive technical operations scale-up experience and extreme fluency in cell therapy tools and services selection process
BOTHELL, Wash., Aug. 25, 2022 /PRNewswire/ --Â BioLife Solutions, Inc. (NASDAQ: BLFS)Â ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapies ("CGT") and the broader biopharma markets, today announced the appointment of Timothy L. Moore to its board of... More



